Anubhav Joshi/LinkedIn, Kishan Davda/LinkedIn
Oct 25, 2026, 17:17
Anubhav Joshi: Evans Syndrome in CLL A Differential Diagnosis to Remember
Anubhav Joshi, Chief Student at Brooklyn USCE/USMLE, shared a post on LinkedIn:
”Evans syndrome—a possibility worth remembering in patients with Chronic Lymphocytic Leukemia
When a patient with CLL develops anemia and thrombocytopenia, disease progression, marrow involvement, and treatment adverse effects often come to mind.
Another differential to consider is immune-mediated destruction of both red blood cells and platelets.
A useful reminder to pause and ask: What is driving this patient’s cytopenias?
The answer can change the approach to treatment.”
Stay updated with Hemostasis Today.
-
Oct 25, 2026, 17:04Tehila Alter: Tracking Hematopoietic Cell Engraftment in Bone Marrow Using CEST MRI
-
Oct 25, 2026, 16:45Shauna Riley։ First Guidelines for Hemoglobin SC Disease
-
Oct 25, 2026, 16:26Heghine Khachatryan: Patient Safety and Clinical Judgment in Platelet Transfusion Decisions
-
Oct 25, 2026, 16:13Funmi (Vanessa) Ullam: From Lived Experience to Research and Innovation in Sickle Cell Care
-
Oct 25, 2026, 15:13Franky Biles: Celebrating Diversity and Driving Inclusion Through Representation
-
Oct 25, 2026, 14:47Siddharth Mittal: A Sheet-Like Effluent Deposit During Plasma Exchange in iTTP
-
Oct 25, 2026, 14:16Alejandro González Veliz: Can Factor XIa Inhibition Prevent Recurrent Ischemic Events Without Increasing Bleeding?
-
Oct 25, 2026, 13:0910 Posts Not to Miss This Week
-
Oct 25, 2026, 13:02Thomas Dayspring: Advancing Cardiovascular Risk Assessment Through Multidisciplinary Lipid Care